1-hexadecene is an unbranched sixteen-carbon alkene with one double bond between C-1 and C-2.
产品中实际含有多少
暂无产品标示该成分含量。
含该成分的产品中，28 款将其列在 1% 线之前，67 款列在之后（通常不超过 1%）。
含有此成分的产品
已确认 95 款中的 12 款 · 按含量充足程度排序 · 查看全部 95 款
AROMATICATea Tree Purifying Shampoo 400ml
MURRENAll Day Moisture Balancing Cleansing Gel
TOSOWOONGFast Boosting Protein Shampoo
KIOSKINKIOSKIN Midinoxide Anti Hair Loss Shampoo
SOME BY MISOME BY MI Yuja Niacin Brightening All-in-One Cleanser 100ml
Derma:BDaily Moisture Foaming Hand Wash 500ml
I'm FromI'm From Mugwort Gel Cleanser
MEDIPEELMEDIPEEL Melanon X Ampoule Cleanser 150ml
DASHUDASHU Daily Herbal Scalp Gold Shampoo EX
DASHUDASHU Daily Herbal Scalp Gold Shampoo EX 500ml (Scalp Strengthening / Hair Loss Relief)
SOOOSwim Body Wash
HEYBRORooted Body Wash Balancing
定义
美国FDA 物质登记 · UNII 38H8547VP0 · 登记名称 HEXADECENE (MIXED ISOMERS) · 混合物
1-hexadecene is an unbranched sixteen-carbon alkene with one double bond between C-1 and C-2.
来源: PubChem
化妆品中的作用
溶解其他成分的基质SOLVENT
安全与法规参考
未列入韩国有毒物质 GHS 分类 · 现有化学物质
Other restriction: ban substances that deplete the ozone layer
来源: 欧盟 CosIng 成分清单
详细资料——标示名称、识别编号、物性、试验记录、文献
官方标示名称和定义
日本化妆品工业联合会标示名称 ヘキサデセン: 本品は、次の化学式で表される不飽和炭化水素である。
来源: 日本化妆品工业联合会标示名称
别名和识别信息
HEXADECENEINCI헥사데센韩国标示名称（食药处标准名）ヘキサデセン日本标示名称
- CAS No.化学物质登记号
- 26952-14-7
- EC No.欧盟化学品目录编号
- 248-131-4
- DTXSID美国EPA化学品编号
- DTXSID90912325
产品实际使用的用途
这是向美国 EPA 申报含该成分的 11 款产品的用途。其中包括化妆品以外的产品，排在前几行的即为该成分的主要用途。
- Viscosity modifier2
- Surfactant (surface active agent)2
- Solvent2
- Sizing agent1
- Lubricating agent1
- Plating agent1
- Processing aids not otherwise specified1
- Fuel1
来源: 美国EPA CompTox
刺激与致敏试验记录
记录有皮肤试验 16 项、眼部试验 4 项。
归类为刺激性高6 项归类为中等3 项归类为低31 项
各项试验结论不一（最多的结论占 15%），因此不能断定该成分有刺激性。 这是对原料本身的试验记录，与成品中所含浓度下的刺激性不同。
查看全部 20 项试验
- Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to other guideline: 16 CFR 1500.41 according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: Magnusson and Kligman - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation) - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) OPPTS 870.2500 according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act (FHSLA) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to - Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to - Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: U.S. EPA FIFRA (Pesticide Assessment Guidelines Subdivision F/TSCA (798.4470) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Register 28 (110), 6.6.1963. paragraph 191.12 Test for eye irritants. according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
来源: 美国EPA CompTox
相关文献
- An endophytic Fusarium sp. isolated from Monarda citriodora produces the industrially important plant-like volatile organic compound hexanal. · 2017
- GCMS analysis and antimicrobial action of latex of Euphorbia caducifolia · 2012
- Contact cheilitis from bisabolol and polyvinylpyrrolidone/hexadecene copolymer in lipstick · 2008
- Peeling cosmetic method using the 8-hexadecene-1,16-dicarboxylic acid · 2005
- Cosmetic peeling method using the 8-hexadecene-1,16-dicarboxylic acid · 2005